Elevance Health Inc.
ELVNYSEAlpha Score of 48 reflects weak overall profile with strong momentum, weak value, weak quality. Based on 3 of 4 signals – score is capped at 90 until remaining data ingests.
Elevance Health Faces Margin Headwinds Amidst Moderate Valuation and Growth Metrics
Apr 15, 2026Elevance Health (ELV) closed today reflecting a complex fundamental picture as the stock trades within its 52-week range of $274.66 to $452.69. The company currently commands a P/E ratio of 32.34, which sits against a backdrop of divergent growth indicators. While revenue growth remains robust at 12.6% year-over-year, earnings per share growth has contracted by 2.0%, resulting in an EPS of 9.69. The firm maintains a thin net margin of 2.8%, highlighting the operational pressures currently influencing the healthcare sector. The broader Alpha Score of 37.2 reflects these mixed signals, with sub-scores of 40.2 for momentum, 39.2 for value, and 44.7 for quality. These metrics suggest that while the company maintains a stable quality profile, the lack of positive sentiment and the decline in earnings growth are weighing on overall market performance. Investors are currently balancing the double-digit revenue expansion against the compression in bottom-line profitability. Market participants should monitor upcoming quarterly earnings reports to determine if margin expansion can align with current revenue growth trajectories.
| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Mar 12, 26 | Schulman Amy W | Director | SELL | 26 | $7K |
| Mar 6, 26 | Kendrick Charles Morgan Jr | EVP & President, Commercial | SELL | 3.2K | $911K |
| Mar 5, 26 | Collis Steven H | Director | BUY | 3.0K | $870K |
| Politician | Date | Type | Amount |
|---|---|---|---|
| Lisa McClain R-MI | 2025-08-13 | sale | $1k – $15k |
| Lisa McClain R-MI | 2025-07-10 | purchase | $1k – $15k |
| Gilbert Cisneros D-CA | 2025-05-30 | sale | $1k – $15k |
| Rob Bresnahan PA | 2025-05-15 | sale | $15k – $50k |
| Jefferson Shreve R-IN | 2025-05-12 | sale | $15k – $50k |
| Gilbert Cisneros D-CA | 2025-04-29 | purchase | $1k – $15k |
| Jared Moskowitz D-FL | 2025-03-10 | sale | $1k – $15k |
| Rob Bresnahan PA | 2025-01-13 | sale | $1k – $15k |
Elevance Health, Inc. is a leading health company that operates through key segments including Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment provides a comprehensive suite of commercial, Medicare, and Medicaid health plans, along with managed care options like preferred provider organizations, serving employers, individuals, families, and communities across multiple states via affiliates such as Anthem Blue Cross and Blue Shield and Wellpoint. CarelonRx delivers pharmacy services to both affiliated health plan members and external customers. Carelon Services integrates physical, behavioral, pharmacy, and social care to support whole health affordably through risk-based solutions, clinical expertise, and partnerships with health plans, government agencies, and providers. This holistic approach addresses physical, behavioral, and social needs, enhanced by digital tools and data insights for better outcomes, affordability, equity, and access. Founded in 1944 and headquartered in Indianapolis, Indiana, Elevance Health plays a pivotal role in the U.S. healthcare market by simplifying care delivery and advancing integrated health solutions for diverse populations.
Earnings calendar coming soon. Subscribe to get notified when ELV reports next.
Get earnings alerts →